AT258875B - Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate - Google Patents

Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate

Info

Publication number
AT258875B
AT258875B AT956163A AT956163A AT258875B AT 258875 B AT258875 B AT 258875B AT 956163 A AT956163 A AT 956163A AT 956163 A AT956163 A AT 956163A AT 258875 B AT258875 B AT 258875B
Authority
AT
Austria
Prior art keywords
preparation
new
aminopropionamide
derivatives
aminopropionamide derivatives
Prior art date
Application number
AT956163A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of AT258875B publication Critical patent/AT258875B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Paper (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AT956163A 1962-12-01 1963-11-29 Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate AT258875B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1414962 1962-12-01

Publications (1)

Publication Number Publication Date
AT258875B true AT258875B (de) 1967-12-11

Family

ID=4398397

Family Applications (1)

Application Number Title Priority Date Filing Date
AT956163A AT258875B (de) 1962-12-01 1963-11-29 Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate

Country Status (3)

Country Link
AT (1) AT258875B (de)
BE (1) BE640639A (de)
GB (1) GB1072118A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664848A (en) 1982-12-23 1987-05-12 The Procter & Gamble Company Detergent compositions containing cationic compounds having clay soil removal/anti-redeposition properties
CA2611944A1 (en) 2005-06-15 2006-12-28 Massachusetts Institute Of Technology Amine-containing lipids and uses thereof
JP6087504B2 (ja) 2008-11-07 2017-03-01 マサチューセッツ インスティテュート オブ テクノロジー アミノアルコールリピドイドおよびその使用
CA2782676C (en) 2009-12-01 2021-06-15 Shire Human Genetic Therapies, Inc. Pharmaceutical compositions for intracellular delivery of nucleic acids and proteins and uses thereof for treatment of ureca cycle metabolic disorders
EP2609135A4 (de) 2010-08-26 2015-05-20 Massachusetts Inst Technology Poly(beta-amino-alkohole), ihre herstellung und verwendungen davon
PL2691443T3 (pl) 2011-03-28 2021-08-30 Massachusetts Institute Of Technology Sprzężone lipomery i ich zastosowania
CA3107288A1 (en) 2011-06-08 2012-12-13 Translate Bio, Inc. Lipid nanoparticle compositions and methods for mrna delivery
EP2859102A4 (de) 2012-06-08 2016-05-11 Shire Human Genetic Therapies Nukleaseresistente polynukleotide und verwendungen davon
EP2882706A1 (de) 2012-08-13 2015-06-17 Massachusetts Institute of Technology Aminhaltige lipoide und ihre verwendungen
EA201591229A1 (ru) 2013-03-14 2016-01-29 Шир Хьюман Дженетик Терапис, Инк. Способы очистки матричной рнк
MX365409B (es) 2013-03-14 2019-05-31 Shire Human Genetic Therapies Composiciones de ácido ribonucleico mensajero del regulador transmembrana de fibrosis quística y métodos y usos relacionados.
US9315472B2 (en) 2013-05-01 2016-04-19 Massachusetts Institute Of Technology 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
EP3060303B1 (de) 2013-10-22 2018-11-14 Translate Bio, Inc. Mrna-therapie für argininosuccinat-synthase-mangel
MX2016005239A (es) 2013-10-22 2016-08-12 Shire Human Genetic Therapies Tratamiento con acido ribonucleico mensajero para la fenilcetonuria.
EP3871696B1 (de) 2013-10-22 2025-03-19 Translate Bio, Inc. Lipidformulierungen zur freisetzung von messenger-rna
KR20250005450A (ko) 2014-04-25 2025-01-09 샤이어 휴먼 지네틱 테라피즈 인크. 메신저 rna 의 정제 방법
BR112016027705A2 (pt) 2014-05-30 2018-01-30 Shire Human Genetic Therapies lipídios biodegradáveis para distribuição de ácidos nucleicos
PE20171238A1 (es) 2014-06-24 2017-08-24 Shire Human Genetic Therapies Composiciones enriquecidas estereoquimicamente para administracion de acidos nucleicos
US9840479B2 (en) 2014-07-02 2017-12-12 Massachusetts Institute Of Technology Polyamine-fatty acid derived lipidoids and uses thereof
EA201991747A1 (ru) 2017-02-27 2020-06-04 Транслейт Био, Инк. НОВАЯ КОДОН-ОПТИМИЗИРОВАННАЯ мРНК CFTR
CA3063531A1 (en) 2017-05-16 2018-11-22 Translate Bio, Inc. Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr
EP3841208A1 (de) 2018-08-24 2021-06-30 Translate Bio, Inc. Verfahren zur reinigung von messenger-rna
MX2021005969A (es) 2018-11-21 2021-09-14 Translate Bio Inc Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr nebulizado.

Also Published As

Publication number Publication date
GB1072118A (en) 1967-06-14
BE640639A (de) 1964-05-29

Similar Documents

Publication Publication Date Title
CH422744A (de) Verfahren zur Herstellung neuer Polyoxyalkylenderivate
CH477448A (de) Verfahren zur Herstellung neuer Imidazolinderivate
AT258875B (de) Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate
AT244965B (de) Verfahren zur Herstellung neuer heterocyclischer Benzocycloheptan-Derivate
CH455828A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH475266A (de) Verfahren zur Herstellung neuer Benzoazacycloalkene
AT249047B (de) Verfahren zur Herstellung neuer Benzamidobenzanilid-Derivate
AT248030B (de) Verfahren zur Herstellung neuer 5'-Sulfoxyde
AT260202B (de) Verfahren zur Herstellung neuer Dibenzocycloheptaenverbindungen
CH407092A (de) Verfahren zur Herstellung basischer Fluoren-Derivate
CH437278A (de) Verfahren zur Herstellung neuer Oestranderivate
CH404674A (de) Verfahren zur Herstellung neuer 3-Alkenyl- und 3-Alkinyl-1-(5-nitrofurfuryliden-amino)-hydantoine
CH464206A (de) Verfahren zur Herstellung von -Aminobenzylpenicillinen
AT265520B (de) Verfahren zur Herstellung neuer Cephalosporinderivate
CH448049A (de) Verfahren zur Herstellung neuer Benzolsulfonylsemicarbazide
CH407119A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH450448A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH480356A (de) Verfahren zur Herstellung neuer Azaphenthiazinderivate
AT251777B (de) Verfahren zur Herstellung neuer Hendekapeptide
CH423050A (de) Verfahren zur Herstellung neuer Diacylaminoanthrachinone
CH420172A (de) Verfahren zur Herstellung neuer 5-Nitrofurylverbindungen
AT243795B (de) Verfahren zur Herstellung neuer Chinolizin-Derivate
CH410950A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH419141A (de) Verfahren zur Herstellung neuer N-Diphenylalkyl-norgranatan- und -nortropan-Derivate
AT248032B (de) Verfahren zur Herstellung neuer 3α-Phenyl-granatan-Derivate